Med-El loses UK appeal in Advanced Bionics fight

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Med-El loses UK appeal in Advanced Bionics fight

Entrance to the Royal Court of Justice

The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor

Hearing implant maker Med-El lost an appeal in its patent fight with Advanced Bionics at the England and Wales Court of Appeal today, May 24.

Lady Justice Kathryn Thirlwall, who handed down the judgment, also had sharp words for Med-El’s representatives over a reference to a deputy High Court judge’s background as a solicitor.

Med-El had challenged the High Court’s decision, issued by Mr Justice Campbell Forsyth in June 2022, to invalidate one of its patents covering cochlear implants.

Arguments began yesterday, May 23, and finished this morning.

The court, which dismissed Med-El’s appeal in full, handed down its verdict this afternoon.

Thirlwall heard the appeal alongside Lord Justices Richard Arnold and Colin Birss.

The full judgment has yet to be published, but Managing IP attended a virtual hand down.

According to Med-El’s counsel, Forsyth made an error in finding the patent obvious over a piece of prior art.

The prior art in question was another patent covering the design of cochlear implants and referred to as ‘Zimmerling’.

Sharp rebuke

At the end of proceedings, Thirlwall criticised Med-El’s representatives over how they referred to Forsyth in their skeleton argument.

The document referred to Forsyth’s job as a partner at Mishcon de Reya and noted that he was appointed to sit as a deputy High Court judge in late 2021.

Thirlwall said these details were irrelevant and “raised eyebrows” among the judges.

“Those matters shouldn’t have been in the skeleton argument.

“It’s no more appealing to do that than to say it was a very strong court,” she told Adrian Speck KC, who argued for Med-El.

Speck said the brief was only meant to identify the judge.

But Thirlwall replied: “His name would have done, and we had that on the judgment.

“I wouldn’t expect to see that sort of observation made in anyone’s skeletons before this court.”

In its own skeleton, Advanced Bionics criticised Med-El for highlighting Forsyth’s training as a solicitor.

“They could also have pointed out that he is a patent specialist of many years’ standing,” the Advanced Bionics brief said.

Solicitor judges are rare in England and Wales, where most High Court judges are former barristers.

An EPO board of appeal upheld an amended version of Med-El’s patent last September.

more from across site and SHARED ros bottom lb

More from across our site

Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Gift this article